Congenital bone fractures in spinal muscular atrophy

Functional role for SMN protein in bone remodeling

Srinivasan Shanmugarajan, Kathryn J. Swoboda, Susan T. Iannaccone, William L. Ries, Bernard L. Maria, Sakamuri V. Reddy

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Spinal muscular atrophy is the second most common fatal childhood disorder. Core clinical features include muscle weakness caused by degenerating lower motor neurons and a high incidence of bone fractures and hypercalcemia. Fractures further compromise quality of life by progression of joint contractures or additional loss of motor function. Recent observations suggest that bone disease in spinal muscular atrophy may not be attributed entirely to lower motor neuron degeneration. The presence of the spinal muscular atrophy disease-determining survival motor neuron gene (SMN), SMN expression, and differential splicing in bone-resorbing osteoclasts was recently discovered. Its ubiquitous expression and the differential expression of splice variants suggest that SMN has specific roles in bone cell function. SMN protein also interacts with osteoclast stimulatory factor. Mouse models of human spinal muscular atrophy disease suggest a potential role of SMN protein in skeletal development. Dual energy x-ray absorptiometry analysis demonstrated a substantial decrease in total bone area and poorly developed caudal vertebra in the mouse model. These mice also had pelvic bone fractures. Studies delineating SMN signaling mechanisms and gene transcription in a cell-specific manner will provide important molecular insights into the pathogenesis of bone disease in children with spinal muscular atrophy. Moreover, understanding bone remodeling in spinal muscular atrophy may lead to novel therapeutic approaches to enhance skeletal health and quality of life. This article reviews the skeletal complications associated with spinal muscular atrophy and describes a functional role for SMN protein in osteoclast development and bone resorption activity.

Original languageEnglish (US)
Pages (from-to)967-973
Number of pages7
JournalJournal of Child Neurology
Volume22
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Spinal Muscular Atrophy
Bone Remodeling
Bone Fractures
Motor Neurons
Proteins
Osteoclasts
Bone Diseases
Muscular Diseases
Bone and Bones
Genes
Quality of Life
Pelvic Bones
Nerve Degeneration
Muscle Weakness
Hypercalcemia
Contracture
Bone Resorption
Spine
Joints
X-Rays

Keywords

  • Bone fractures
  • Osteoclasts
  • SMN protein
  • Spinal muscular atrophy

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Cite this

Congenital bone fractures in spinal muscular atrophy : Functional role for SMN protein in bone remodeling. / Shanmugarajan, Srinivasan; Swoboda, Kathryn J.; Iannaccone, Susan T.; Ries, William L.; Maria, Bernard L.; Reddy, Sakamuri V.

In: Journal of Child Neurology, Vol. 22, No. 8, 08.2007, p. 967-973.

Research output: Contribution to journalArticle

Shanmugarajan, Srinivasan ; Swoboda, Kathryn J. ; Iannaccone, Susan T. ; Ries, William L. ; Maria, Bernard L. ; Reddy, Sakamuri V. / Congenital bone fractures in spinal muscular atrophy : Functional role for SMN protein in bone remodeling. In: Journal of Child Neurology. 2007 ; Vol. 22, No. 8. pp. 967-973.
@article{4e03376cc0fe46ee9ac6f6be9bb3bbfc,
title = "Congenital bone fractures in spinal muscular atrophy: Functional role for SMN protein in bone remodeling",
abstract = "Spinal muscular atrophy is the second most common fatal childhood disorder. Core clinical features include muscle weakness caused by degenerating lower motor neurons and a high incidence of bone fractures and hypercalcemia. Fractures further compromise quality of life by progression of joint contractures or additional loss of motor function. Recent observations suggest that bone disease in spinal muscular atrophy may not be attributed entirely to lower motor neuron degeneration. The presence of the spinal muscular atrophy disease-determining survival motor neuron gene (SMN), SMN expression, and differential splicing in bone-resorbing osteoclasts was recently discovered. Its ubiquitous expression and the differential expression of splice variants suggest that SMN has specific roles in bone cell function. SMN protein also interacts with osteoclast stimulatory factor. Mouse models of human spinal muscular atrophy disease suggest a potential role of SMN protein in skeletal development. Dual energy x-ray absorptiometry analysis demonstrated a substantial decrease in total bone area and poorly developed caudal vertebra in the mouse model. These mice also had pelvic bone fractures. Studies delineating SMN signaling mechanisms and gene transcription in a cell-specific manner will provide important molecular insights into the pathogenesis of bone disease in children with spinal muscular atrophy. Moreover, understanding bone remodeling in spinal muscular atrophy may lead to novel therapeutic approaches to enhance skeletal health and quality of life. This article reviews the skeletal complications associated with spinal muscular atrophy and describes a functional role for SMN protein in osteoclast development and bone resorption activity.",
keywords = "Bone fractures, Osteoclasts, SMN protein, Spinal muscular atrophy",
author = "Srinivasan Shanmugarajan and Swoboda, {Kathryn J.} and Iannaccone, {Susan T.} and Ries, {William L.} and Maria, {Bernard L.} and Reddy, {Sakamuri V.}",
year = "2007",
month = "8",
doi = "10.1177/0883073807305664",
language = "English (US)",
volume = "22",
pages = "967--973",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - Congenital bone fractures in spinal muscular atrophy

T2 - Functional role for SMN protein in bone remodeling

AU - Shanmugarajan, Srinivasan

AU - Swoboda, Kathryn J.

AU - Iannaccone, Susan T.

AU - Ries, William L.

AU - Maria, Bernard L.

AU - Reddy, Sakamuri V.

PY - 2007/8

Y1 - 2007/8

N2 - Spinal muscular atrophy is the second most common fatal childhood disorder. Core clinical features include muscle weakness caused by degenerating lower motor neurons and a high incidence of bone fractures and hypercalcemia. Fractures further compromise quality of life by progression of joint contractures or additional loss of motor function. Recent observations suggest that bone disease in spinal muscular atrophy may not be attributed entirely to lower motor neuron degeneration. The presence of the spinal muscular atrophy disease-determining survival motor neuron gene (SMN), SMN expression, and differential splicing in bone-resorbing osteoclasts was recently discovered. Its ubiquitous expression and the differential expression of splice variants suggest that SMN has specific roles in bone cell function. SMN protein also interacts with osteoclast stimulatory factor. Mouse models of human spinal muscular atrophy disease suggest a potential role of SMN protein in skeletal development. Dual energy x-ray absorptiometry analysis demonstrated a substantial decrease in total bone area and poorly developed caudal vertebra in the mouse model. These mice also had pelvic bone fractures. Studies delineating SMN signaling mechanisms and gene transcription in a cell-specific manner will provide important molecular insights into the pathogenesis of bone disease in children with spinal muscular atrophy. Moreover, understanding bone remodeling in spinal muscular atrophy may lead to novel therapeutic approaches to enhance skeletal health and quality of life. This article reviews the skeletal complications associated with spinal muscular atrophy and describes a functional role for SMN protein in osteoclast development and bone resorption activity.

AB - Spinal muscular atrophy is the second most common fatal childhood disorder. Core clinical features include muscle weakness caused by degenerating lower motor neurons and a high incidence of bone fractures and hypercalcemia. Fractures further compromise quality of life by progression of joint contractures or additional loss of motor function. Recent observations suggest that bone disease in spinal muscular atrophy may not be attributed entirely to lower motor neuron degeneration. The presence of the spinal muscular atrophy disease-determining survival motor neuron gene (SMN), SMN expression, and differential splicing in bone-resorbing osteoclasts was recently discovered. Its ubiquitous expression and the differential expression of splice variants suggest that SMN has specific roles in bone cell function. SMN protein also interacts with osteoclast stimulatory factor. Mouse models of human spinal muscular atrophy disease suggest a potential role of SMN protein in skeletal development. Dual energy x-ray absorptiometry analysis demonstrated a substantial decrease in total bone area and poorly developed caudal vertebra in the mouse model. These mice also had pelvic bone fractures. Studies delineating SMN signaling mechanisms and gene transcription in a cell-specific manner will provide important molecular insights into the pathogenesis of bone disease in children with spinal muscular atrophy. Moreover, understanding bone remodeling in spinal muscular atrophy may lead to novel therapeutic approaches to enhance skeletal health and quality of life. This article reviews the skeletal complications associated with spinal muscular atrophy and describes a functional role for SMN protein in osteoclast development and bone resorption activity.

KW - Bone fractures

KW - Osteoclasts

KW - SMN protein

KW - Spinal muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=34548157263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548157263&partnerID=8YFLogxK

U2 - 10.1177/0883073807305664

DO - 10.1177/0883073807305664

M3 - Article

VL - 22

SP - 967

EP - 973

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 8

ER -